ProMED Update  by unknown
International Journal of Infectious Diseases (2004) 8, 199—200
ProM
ED
U
pdate
ProMED Update
A review of emerging diseases reported on ProMED-mail www.promedmail.org
Fiona J. Cooke, Daniel S. Shapiro
Nipah Virus in Bangladesh
An outbreak of Nipah virus encephalitis, which occurred in the Faridpur District of Bangladesh, was responsible for 34 cases, including
26 deaths and has now ended (ProMed mail archive number 20040528.1445; http://www.cdc.gov/travel/other/nipah bangladesh
2004.htm). No new cases have been reported since mid-April. The Centers for Disease Control and Prevention (CDC) conﬁrmed Nipah
virus infection in 16 of the cases. Laboratory conﬁrmation on patient specimens included, in speciﬁc cases, the demonstration of
IgM antibodies to Nipah virus, positive viral cultures, and positive RT-PCR assays. Of note, the RT-PCR assays demonstrated a Nipah
virus with about a 95% homology to the sequence of the isolate from the Malaysian outbreak in 1999 was the cause of this outbreak
(ProMED mail archive number 20040423.1127; http://www.who.int/wer/2004/wer7917/en/).
Outbreaks of Nipah virus encephalitis have previously occurred in Bangladesh in May 2001, January/February 2003, and January/
February 2004. The largest outbreak, of over 250 cases and with approximately a 40% case-fatality rate, occurred in Malaysia and
Singapore in 1999.
Nipah virus, which was discovered in 1999, is a zoonotic virus. Fruit bats of the genus Pteropus are thought to be the reservoir for
this virus. The initial outbreak in Malaysia and Singapore affected humans and commercial swineherds, although other species,
including cats, dogs, and horses, were also infected. Of note, investigation in the Goalanda, Rajbari district in this 2004 out-
break was unable to establish any link between the cases and sick pigs. A number of those affected were boys who collected
and ate fruit in trees before dawn, which generated the hypothesis that fruit bats directly contaminated the consumed fruit
(http://www.who.int/wer/2004/wer7917/en/>).
The virus mainly caused respiratory illness among the pigs and an encephalitis syndrome among humans. Nipah virus infection can
cause fever, headache, vomiting, dizziness, myalgias, altered consciousness, seizure, respiratory distress, and encephalitis.
Fatal Ebola Laboratory Accident, Siberia
On 5 May 2004 a scientist working with guinea-pigs who had been infected with Ebola virus at the Vector State Research Center of
Virology and Biotechnology in central Siberia accidentally pricked herself with a needle (ProMED mail archive number 20040522.1377).
She was based in the Department of Dangerous Viral Pathogens of the Molecular Biology Scientiﬁc Research Institute. After the incident
she was hospitalized in the department of dangerous infections at a specialist hospital with the greatest possible level of biological
defence, according to reports from the Vector Center. In spite of treatment (details not speciﬁed), the scientist unfortunately died
on 19 May. There is no vaccine or speciﬁc therapy for Ebola virus.
Ebola virus is spread by contact with body ﬂuids, including sweat and saliva. All research and medical personnel who had been in
contact with the patient were to remain under close medical observation for 3 weeks. This involved daily medical examination and
twice-daily temperature measurement.
The Vector State Research Center of Virology and Biotechnology was set up in 1974 under the Russian Health Ministry to study dangerous
viral pathogens and to develop treatment and diagnostic preparations in the interests of health care and defence. According to a
spokesman, it now conducts research on Ebola and Marburg viruses in order to develop speciﬁc vaccines. There have been at least two
other cases of accidental contraction of a potentially fatal virus at the Vector State Research Center. In 1988 a researcher accidentally
contracted Marburg virus and died, while in 1990 another worker contracted the same virus and survived. In 1996 an incident involving
Ebola virus occurred at another Russian biological research centre, the Defence Ministry’s Virology Center in Sergiyev Posad near
Moscow, when a worker accidentally contracted the virus and died.
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This is the second case of accidental laboratory exposure to Ebola virus reported by ProMED mail this year. Back in February a
scientist based at Fort Detrick, Maryland accidentally grazed her hand with a needle while injecting mice who had been infected with
a modiﬁed form of Ebola virus (ProMED mail archive number 20040220.0550.). Fortunately the scientist did not develop haemorrhagic
fever and she survived.
Ebola Haemorrhagic Fever, Sudan
By 26 May 2004, the health authorities had reported 20 cases of Ebola Haemorrhagic Fever in the town of Yambio, Western Equatoria,
southern Sudan (ProMED mail archive number 20040527.1435). There had been ﬁve deaths. Laboratory tests at the Centers for Disease
Control and Prevention (CDC), Atlanta, USA and the Kenya Medical Research Institute (KEMRI), Nairobi, had conﬁrmed the presence
of Ebola virus, sub-type Sudan. Over 100 other people who had been in contact with patients were being monitored.
Teams from the WHO South Sudan Early Warning and Response Network (EWARN) and from WHO headquarters are working with the
Crisis Committee to try to control the outbreak. Personnel from Medecins sans Frontieres are helping to manage cases in Yambio
hospital, and other non governmental organizations and churches are also involved.
The Northern Border Region of Uganda and the Democratic Republic of Congo (DRC) have enhanced surveillance in bordering areas.
Concern is particularly high in the DRC, where an outbreak earlier this year killed more than 120 people. Experts in Kenya (which also
borders Sudan) are proposing strict border controls, involving screening all visitors and aid workers entering Kenya from the Sudan,
to try to prevent the spread of the virus into Kenya.
There are four distinct species of Ebola virus: Sudan Ebola virus, Cote d’Ivoire Ebola virus, Reston Ebola virus, and Zaire Ebola
virus(ProMED mail archive number 20040525.1404). The isolates responsible for the outbreaks in Sudan in 1976 and 1979 cluster with
the viruses isolated from primates imported into an animal facility in Reston, Virginia, USA, which proved to have limited pathogenicity
for humans. These are phylogenetically distinct from the viruses associated with the haemorrhagic fever outbreaks in Cote d’Ivoire
(in 1994), Gabon (in 1996), and Zaire (in 1976 and 1995), which all cluster together.
